{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T12:05:21Z","timestamp":1784462721400,"version":"3.55.0"},"reference-count":0,"publisher":"Knowledge E DMCC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJHOSCR"],"abstract":"<jats:p>Background: Multiple myeloma is a heterogeneous malignancy with patchy bone marrow involvement, often leading to discrepancies between biochemical and imaging-based response assessments. Site-specific bone marrow biopsies may miss focal disease, while FDG PET\/CT detects metabolically active lesions, offering complementary prognostic value.\r\nMaterials and Methods: This prospective study included 44 newly diagnosed multiple myeloma patients. The primary aim was to assess the correlation between biochemical and PET\/CT responses at six months post-induction. A secondary objective was to evaluate the impact of PET\/CT response on 12-month EFS.\r\nResults: The median age was 55.5 years. At baseline, &gt;3 focal lesions and EMD were observed in 61.4% and 34.1% of patients, respectively. After six months of induction therapy, 86.3% achieved \u2265VGPR biochemically, but 52.3% remained PET\/CT-positive. Baseline &gt;3 focal lesions and extramedullary disease (EMD) significantly predicted persistent PET\/CT positivity (p = 0.004). Notably, 50% of patients with \u2265VGPR (very good partial response) still showed PET\/CT-positive findings. At 12 months, 75% of patients with clinical events had positive PET\/CT at six months versus 47.2% without events (p = 0.245). Event-free survival was lower in the PET\/CT-positive group (73.9% vs. 90.4%, p = 0.182), though not statistically significant.\r\nConclusion: 18-FDG PET\/CT can detect residual disease not captured by biochemical markers, highlighting the value of combined assessment in multiple myeloma. Baseline &gt;3 focal lesions and EMD predicted persistent PET\/CT positivity. Although PET\/CT positivity at six months showed a trend toward worse 12-month EFS, larger studies are needed to confirm its prognostic significance.<\/jats:p>","DOI":"10.18502\/ijhoscr.v20i2.21781","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:57:03Z","timestamp":1781953023000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation of Biochemical and FDG PET\/CT Responses Following Induction Therapy In Newly Diagnosed Multiple Myeloma: A Prospective Observational Study"],"prefix":"10.18502","author":[{"given":"Homdutt","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelabh","family":"Nayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulika","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmita","family":"Dass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh Kumar","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoranjan","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7770","published-online":{"date-parts":[[2026,6,20]]},"container-title":["International Journal of Hematology-Oncology and Stem Cell Research"],"original-title":[],"link":[{"URL":"https:\/\/publish.kne-publishing.com\/index.php\/IJHOSCR\/article\/download\/21781\/20290","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publish.kne-publishing.com\/index.php\/IJHOSCR\/article\/download\/21781\/20290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T12:00:36Z","timestamp":1784462436000},"score":1,"resource":{"primary":{"URL":"https:\/\/publish.kne-publishing.com\/index.php\/IJHOSCR\/article\/view\/21781"},"secondary":[{"URL":"https:\/\/ijhoscr.tums.ac.ir\/index.php\/ijhoscr\/article\/view\/2477","label":"UNIVERSITY"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":0,"URL":"https:\/\/doi.org\/10.18502\/ijhoscr.v20i2.21781","relation":{},"ISSN":["2008-2207"],"issn-type":[{"value":"2008-2207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]}}}